526 related articles for article (PubMed ID: 17904174)
1. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
2. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells.
Sadikovic B; Rodenhiser DI
Toxicol Appl Pharmacol; 2006 Nov; 216(3):458-68. PubMed ID: 16926039
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
4. Techniques used in studies of age-related DNA methylation changes.
Wojdacz TK; Hansen LL
Ann N Y Acad Sci; 2006 May; 1067():479-87. PubMed ID: 16804030
[TBL] [Abstract][Full Text] [Related]
5. Microarray-based DNA methylation profiling: technology and applications.
Schumacher A; Kapranov P; Kaminsky Z; Flanagan J; Assadzadeh A; Yau P; Virtanen C; Winegarden N; Cheng J; Gingeras T; Petronis A
Nucleic Acids Res; 2006; 34(2):528-42. PubMed ID: 16428248
[TBL] [Abstract][Full Text] [Related]
6. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
[TBL] [Abstract][Full Text] [Related]
7. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Yan PS; Perry MR; Laux DE; Asare AL; Caldwell CW; Huang TH
Clin Cancer Res; 2000 Apr; 6(4):1432-8. PubMed ID: 10778974
[TBL] [Abstract][Full Text] [Related]
8. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites.
Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI
Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500
[TBL] [Abstract][Full Text] [Related]
9. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
[TBL] [Abstract][Full Text] [Related]
10. [Perspective of DNA methylation in forensic genetics and new progress of its detection methods].
Zhao SM; Li CT
Fa Yi Xue Za Zhi; 2009 Aug; 25(4):290-5. PubMed ID: 19788082
[TBL] [Abstract][Full Text] [Related]
11. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
12. Oligonucleotide-based microarray for DNA methylation analysis: principles and applications.
Shi H; Maier S; Nimmrich I; Yan PS; Caldwell CW; Olek A; Huang TH
J Cell Biochem; 2003 Jan; 88(1):138-43. PubMed ID: 12461783
[TBL] [Abstract][Full Text] [Related]
13. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
Nouzova M; Holtan N; Oshiro MM; Isett RB; Munoz-Rodriguez JL; List AF; Narro ML; Miller SJ; Merchant NC; Futscher BW
J Pharmacol Exp Ther; 2004 Dec; 311(3):968-81. PubMed ID: 15302897
[TBL] [Abstract][Full Text] [Related]
14. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
15. Global, comparative analysis of tissue-specific promoter CpG methylation.
Schilling E; Rehli M
Genomics; 2007 Sep; 90(3):314-23. PubMed ID: 17582736
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
Tryndyak V; Kovalchuk O; Pogribny IP
Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
[TBL] [Abstract][Full Text] [Related]
17. EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines.
Grafodatskaya D; Choufani S; Ferreira JC; Butcher DT; Lou Y; Zhao C; Scherer SW; Weksberg R
Genomics; 2010 Feb; 95(2):73-83. PubMed ID: 20005943
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets.
Ordway JM; Bedell JA; Citek RW; Nunberg A; Garrido A; Kendall R; Stevens JR; Cao D; Doerge RW; Korshunova Y; Holemon H; McPherson JD; Lakey N; Leon J; Martienssen RA; Jeddeloh JA
Carcinogenesis; 2006 Dec; 27(12):2409-23. PubMed ID: 16952911
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.
Piotrowski A; Benetkiewicz M; Menzel U; Díaz de Ståhl T; Mantripragada K; Grigelionis G; Buckley PG; Jankowski M; Hoffman J; Bała D; Srutek E; Laskowski R; Zegarski W; Dumanski JP
Genes Chromosomes Cancer; 2006 Jul; 45(7):656-67. PubMed ID: 16575877
[TBL] [Abstract][Full Text] [Related]
20. Promoter analysis of epigenetically controlled genes in bladder cancer.
Veerla S; Panagopoulos I; Jin Y; Lindgren D; Höglund M
Genes Chromosomes Cancer; 2008 May; 47(5):368-78. PubMed ID: 18196590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
